CAS: 1338452-54-2
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Everolimus-d4 (~90%) REF: IN-DA01CB7WCAS: 1338452-54-2 | 98% | To inquire | Tue 10 Dec 24 |
 | Everolimus-d4 REF: 4Z-E-102CAS: 1338452-54-2 | - - - | To inquire | Tue 10 Dec 24 |
 | Everolimus-d4 (~90%) REF: TR-E945402CAS: 1338452-54-2 | ~90% | 401.00 €~2,709.00 € | Mon 16 Dec 24 |
 | Everolimus-d4, 90% REF: 3D-FE177683CAS: 1338452-54-2 | Min. 95% | To inquire | Fri 17 Jan 25 |
Everolimus-d4 (~90%)
CAS:1338452-54-2
Formula:
C53H79D4NO14
Purity:
98%
Color and Shape:
Solid
Molecular weight:
962.2491
Ref: IN-DA01CB7W
| 1mg | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Everolimus-d4
CAS:1338452-54-2
Formula:
C53H79D4NO14
Color and Shape:
White To Off-White Solid
Molecular weight:
962.26
Ref: 4Z-E-102
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Everolimus-d4 (~90%)
Controlled ProductCAS:1338452-54-2
Applications Macrolide immunosuppressant; derivative of Rapamycin. Inhibits cytokine-mediated lymphocyte proliferation. Not a dangerous good if …
Formula:
C53H4H79NO14
Purity:
~90%
Color and Shape:
White To Light Yellow
Molecular weight:
962.25
Ref: TR-E945402
| 1mg | 401.00 € | ||
| 10mg | 2,709.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
Everolimus-d4, 90%
CAS:1338452-54-2
Everolimus is a calcineurin inhibitor that has been approved for the treatment of cancers. It …
Formula:
C53H79D4NO14
Purity:
Min. 95%
Molecular weight:
962.25 g/mol
Ref: 3D-FE177683
| 1mg | To inquire | ||
| 2mg | To inquire | ||
| 5mg | To inquire | ||
| 10mg | To inquire |
Estimated delivery in United States, on Friday 17 Jan 2025
